1 Min Read
Feb 28 (Reuters) - Compumedics Ltd:
* “Targeting a strong second half”
* Full year revenue guidance amended to $38m-$42m, EBITDA $4.5m-$7.5m, NPAT $2.5m-$5.5m Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.